Concentrix is trading at $22.48, down 10.17%, after its September 29 earnings release showed revenue down 1.2% year over year and a $1.05 billion non-cash goodwill impairment. - Non-GAAP EPS of $2.92 beat estimates; revenue was $2.454 billion. - Full-year revenue guidance was $9.827–$9.877 billion. - The impairment drove a reported operating loss, while adjusted operating margin expanded and operating cash flow reached a third-quarter record.